TECH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TECH is quite expensive at the moment. It does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROIC | 9.33% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Altman-Z | 12.43 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.04 | ||
| Fwd PE | 29.37 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.69 | ||
| EV/EBITDA | 27.22 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
65.7
+1.12 (+1.73%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.04 | ||
| Fwd PE | 29.37 | ||
| P/S | 8.41 | ||
| P/FCF | 45.69 | ||
| P/OCF | 40.74 | ||
| P/B | 5.21 | ||
| P/tB | 16.08 | ||
| EV/EBITDA | 27.22 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROCE | 11.3% | ||
| ROIC | 9.33% | ||
| ROICexc | 9.93% | ||
| ROICexgc | 24.48% | ||
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% | ||
| FCFM | 18.41% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 25.63% | ||
| Cap/Sales | 2.24% | ||
| Interest Coverage | 14.5 | ||
| Cash Conversion | 66.94% | ||
| Profit Quality | 291.58% | ||
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 | ||
| Altman-Z | 12.43 |
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
ChartMill assigns a valuation rating of 3 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Overvalued.
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.
The dividend rating of BIO-TECHNE CORP (TECH) is 4 / 10 and the dividend payout ratio is 65.26%.